Cargando…
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
INTRODUCTION: Iron deficiency anemia (IDA) is common in patients with gastrointestinal (GI) disorders and can adversely affect quality of life. Oral iron is poorly tolerated in many patients with GI disorders. Ferumoxytol is approved for the intravenous treatment of IDA in patients with chronic kidn...
Autores principales: | Ford, David C, Dahl, Naomi V, Strauss, William E, Barish, Charles F, Hetzel, David J, Bernard, Kristine, Li, Zhu, Allen, Lee F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946860/ https://www.ncbi.nlm.nih.gov/pubmed/27468245 http://dx.doi.org/10.2147/CEG.S101473 |
Ejemplares similares
-
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017) -
Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019) -
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia
previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014) -
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
por: Hetzel, David, et al.
Publicado: (2014) -
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
por: Vadhan-Raj, Saroj, et al.
Publicado: (2016)